Article Information
History
- February 8, 2021.
Article Versions
- Version 2 (February 2, 2021 - 15:41).
- Version 1 (February 3, 2021 - 20:48).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mathew Chamberlain1,
- Richa Hanamsagar1,
- Frank O. Nestle2,
- Emanuele de Rinaldis1 and
- Virginia Savova1,*
- 1Immunology and Inflammation Research Therapeutic Area, Sanofi, 270 Albany Street, Cambridge, MA 02139, USA
- 2Sanofi Research and Development, Cambridge, MA 02139, USA
- ↵*Correspondence: Virginia.Savova{at}sanofi.com